MedTrace Logo

Evaluation of CG-100 Intraluminal Bypass Device

NCT05632744 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2024-02-14

No results posted yet for this study

Summary

Evaluation of CG-100 Intraluminal Bypass device

Conditions

Interventions

DEVICE

CG-100 Intraluminal Bypass Device

Subjects will be treated with the CG-100 Intraluminal Bypass Device

Sponsors & Collaborators

  • Colospan Ltd.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-15
Primary Completion
2024-06-15
Completion
2024-06-15

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05632744 on ClinicalTrials.gov